Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled Ingredients.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Landmesser (2019)
Understanding heterogeneity among individuals who smoke cigarettes and vape: assessment of biomarkers of exposure and potential harm among subpopulations from the PaTh Wave 1 Data.
Individual Clinical
Biomarkers
ALL
Lizhnyak (2022)
Comparison of Urinary Biomarkers of Exposure in humans Using Electronic Cigarettes, Combustible Cigarettes, and Smokeless Tobacco.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Lorkiewicz (2019)
Cluster analysis of urinary tobacco biomarkers among U.S. adults: Population assessment of Tobacco and health (PaTh) biomarker study (2013-2014).
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Majeed (2020)
Lipid profiles in users of combustible and electronic cigarettes.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Majid (2021)
Secondhand exposure to aerosol from electronic cigarettes: pilot study of assessment of tobacco-specific nitrosamine (NNaL) in urine.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Martínez-Sánchez (2019)
Recent updates on biomarkers of exposure and systemic toxicity in e-cigarette users and EVaLI.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
McDonough (2021)
Effects of Switching to Electronic Cigarettes with and without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and acrolein
Individual Clinical
Biomarkers
Biomarkers Of Exposure
McRobbie (2015)
Specific biomarker comparison in current smokers, e-cigarette users, and non-smokers.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Melero-Ollonarte (2023)
Cardiovascular impact of electronic-cigarette use
Individual Clinical
Biomarkers
Biomarkers Of Harm
Middlekauff (2020)